SOPHiA GENETICS (SOPH) Gross Profit (2020 - 2025)

SOPHiA GENETICS's Gross Profit history runs 6 years deep, the most recent figure standing at $14.7 million for Q4 2025.

• In Q4 2025, Gross Profit rose 21.4% year-over-year to $14.7 million; the TTM figure through Dec 2025 stood at $52.1 million (up 18.53% YoY), while the FY2025 annual figure was $52.1 million, up 18.53% from the prior year.
• Gross Profit came in at $14.7 million for Q4 2025 at SOPHiA GENETICS, up from $12.9 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $6230.0 billion in Q2 2021 to a low of $5.6 million in Q1 2021.
• A 5-year average of $311.5 billion and a median of $10.5 million in 2024 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit surged 156985.22% in 2021 and tumbled 100.0% in 2022, its largest moves.
• SOPHiA GENETICS's Gross Profit stood at $6.8 million in 2021, then surged by 41.01% to $9.6 million in 2022, then rose by 23.54% to $11.9 million in 2023, then rose by 1.71% to $12.1 million in 2024, then gained by 21.4% to $14.7 million in 2025.
• According to Business Quant data, Gross Profit over the past three periods registered $14.7 million, $12.9 million, and $12.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison